Elevance Health Files 8-K

TL;DR

ELEVANCE HEALTH FILED AN 8-K. NO MAJOR NEWS.

AI Summary

Elevance Health, Inc. filed an 8-K on June 12, 2024, to report information under Regulation FD. The filing does not contain specific financial figures or material events beyond the standard reporting requirements for this form type.

Why It Matters

This filing indicates Elevance Health is adhering to its reporting obligations with the SEC, which is standard practice for publicly traded companies.

Risk Assessment

Risk Level: low — The filing is a routine 8-K for Regulation FD disclosure and does not contain any new material information that would impact risk.

Key Players & Entities

• Elevance Health, Inc. (company) — Registrant
• 001-16751 (company) — Commission File Number
• 35-2145715 (company) — I.R.S. Employer Identification Number
• 220 Virginia Ave Indianapolis, IN 46204 (company) — Address of principal executive offices

FAQ

Key Financial Figures

• $0.01 — ch registered Common Stock, Par Value $0.01 ELV NYSE Indicate by check mark wheth
• $34.05 — e for full year 2024 to be greater than $34.05 per diluted share, including approximat
• $3.15 — diluted share, including approximately $3.15 per diluted share of net unfavorable it
• $37.20 — adjusted net income to be greater than $37.20 per diluted share. This guidance does n

Filing Documents

• item701guidancejune2024.htm (8-K) — 25KB
• 0001156039-24-000093.txt ( ) — 27KB

01 - Regulation FD Disclosure

Item 7.01 - Regulation FD Disclosure Officers of Elevance Health, Inc. (the "Company") will speak with investors over the next several weeks. During these meetings, Company officers intend to reaffirm the Company's net income guidance for full year 2024 to be greater than $34.05 per diluted share, including approximately $3.15 per diluted share of net unfavorable items. Excluding these items, the Company continues to expect adjusted net income to be greater than $37.20 per diluted share. This guidance does not include any other adjustment items beyond those reported in the Company's first quarter 2024 earnings release. None of the information furnished in Item 7.01 hereto shall be deemed to be "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended. Unless expressly set forth by specific reference in such filings, none of the information furnished in this report shall be incorporated by reference in any filing under the Securities Act of 1933, as amended, whether made before or after the date hereof and regardless of any general incorporation language in such filings.

FORWARD-LOOKING STATEMENTS

FORWARD-LOOKING STATEMENTS This document contains certain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements reflect our views about future events and financial performance and are generally not historical facts. Words such as "expect," "feel," "believe," "will," "may," "should," "anticipate," "intend," "estimate," "project," "forecast," "plan" and similar expressions are intended to identify forward-looking statements. These statements include, but are not limited to financial projections and estimates and their underlying assumptions statements regarding plans, objectives and expectations with respect to future operations, products and services and statements regarding future performance. Such statements are subject to certain risks and uncertainties, many of which are difficult to predict and generally beyond our control, that could cause actual results to differ materially from those expressed in, or implied or projected by, the forward-looking statements. You are cautioned not to place undue reliance on these forward-looking statements that speak only as of the date hereof. You are also urged to carefully review and consider the various risks and other disclosures discussed in our reports filed with the U.S. Securities and Exchange Commission from time to time, which attempt to advise interested parties of the factors that affect our business. Except to the extent required by law, we do not update or revise any forward-looking statements to reflect events or circumstances occurring after the date hereof. These risks and uncertainties include, but are not limited to trends in healthcare costs and utilization rates reduced enrollment our ability to secure and implement sufficient premium rates the impact of large scale medical emergencies, such as public health epidemics and pandemics, and other catastrophes the impact of new or changes in existing federal, state and international la

View Full Filing

View this 8-K filing on SEC EDGAR